2025 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Opportunities Report
Description
The 2025 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cancer Immunotherapy Drug Discovery Outsourcing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Cancer Immunotherapy Drug Discovery Outsourcing Market in Japan include Crown Bioscience, Ono Pharmaceutical, Personalis, Inc., and Modulus Discovery. Crown Bioscience, in a joint venture with Medical & Biological Laboratories (MBL), provides extensive drug discovery and development services in Japan, leveraging advanced technologies like organoids, high-content imaging, and a large PDX model collection to support oncology and immuno-oncology research locally. Ono Pharmaceutical collaborates with Bristol-Myers Squibb, focusing on clinical research and commercialization of immunotherapies such as Opdivo® (nivolumab) in Japan, supported by outsourcing agreements with institutions like PRiME-R for real-world data management.
Personalis, Inc. partners with global firms like Moderna to develop personalized cancer vaccines by sequencing tumor genomic information, enhancing tailored immunotherapy solutions. Modulus Discovery, a Tokyo-based biotech, accelerates preclinical drug discovery for cancer and other diseases using supercomputing and structural biology, recently expanding through large funding rounds to enhance infrastructure and collaborations in Japan. These companies represent a blend of local presence, cutting-edge technology, and strategic partnerships driving cancer immunotherapy drug discovery outsourcing in Japan.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cancer Immunotherapy Drug Discovery Outsourcing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Cancer Immunotherapy Drug Discovery Outsourcing Market in Japan include Crown Bioscience, Ono Pharmaceutical, Personalis, Inc., and Modulus Discovery. Crown Bioscience, in a joint venture with Medical & Biological Laboratories (MBL), provides extensive drug discovery and development services in Japan, leveraging advanced technologies like organoids, high-content imaging, and a large PDX model collection to support oncology and immuno-oncology research locally. Ono Pharmaceutical collaborates with Bristol-Myers Squibb, focusing on clinical research and commercialization of immunotherapies such as Opdivo® (nivolumab) in Japan, supported by outsourcing agreements with institutions like PRiME-R for real-world data management.
Personalis, Inc. partners with global firms like Moderna to develop personalized cancer vaccines by sequencing tumor genomic information, enhancing tailored immunotherapy solutions. Modulus Discovery, a Tokyo-based biotech, accelerates preclinical drug discovery for cancer and other diseases using supercomputing and structural biology, recently expanding through large funding rounds to enhance infrastructure and collaborations in Japan. These companies represent a blend of local presence, cutting-edge technology, and strategic partnerships driving cancer immunotherapy drug discovery outsourcing in Japan.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
